Publisher's Synopsis
This monograph provides an assessment of the number one concern in contemporary drug development, namely how toxic side effects can be predicted and thereby prevented before a drug enters the clinical trial stage.
In first part, general concepts of drug toxicity and adverse drug reactions are surveyed, based on the most recent scientific evidence, while the second part contains an in–depth analysis of modern in vitro methods in predictive toxicology. The third and final part is devoted to the discussion of future challenges facing the pharmaceuticals industry.
With its emphasis on current and future developments, this is key knowledge for every professional in the drug development business needing to stay ahead of the competition.
